Canntab Therapeutics
1 follower
Canntab Therapeutics ahs developed a product line of solid oral dose delivery systems including extended release (XR), flash melt, immediate release, modified release and bi-layered tablet solutions that provide a variety of cannabinoid and terpenoid blends in exacting dosages.
Org chart
Jeff Renwick
CEO
Jeff Renwick
Collapse
Eric Malinski
Director Of Marketing
Larry Latowsky
Special Advisor
Robert Lefler
Director of Operations
Tommy Larocque
Procurement
